HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application ...

HeartBeam is pursuing several parallel paths to address the FDA’s concerns, including a potential appeal process or resubmission of a 510 (k) application. The company noted that the appeal process ...

The accumulation of fatty deposits inside arteries leads to their narrowing, which blocks blood flow to heart tissue, and ...

Note: Some stories include subjects of graphic medical imagery, gun violence, and drug abuse. Please proceed with caution. 1.

If you’re looking to score the best discounts on Black Friday, we suggest scrolling through these Best Buy deals.

HeartBeam (BEAT) announced its regulatory strategy following receipt of a Not Substantially Equivalent, or NSE, decision on the company’s 510(k) ...

HeartBeam shares jumped 40.75% in after-hours trading after the company outlined its regulatory strategy following the FDA's Not Substantially Equivalent decision.

Smartwatch trends in 2025 bring larger screens, advanced sensors, and AI-driven health tracking, making wearable tech updates ...

Exciting developments are on the horizon for Medinirai Medical College and Hospital in Daltonganj, as they prepare to introduce new diploma courses sp ...

Heart failure is a condition that many people face with age, but cases of a rare heart condition tied to a genetic mutation are on the rise. Learn what transthyretin amyloid cardiomyopathy (ATTR-CM) ...

Smriti Mandhana’s wedding was postponed after her father, Shrinivas Mandhana, was hospitalised with sudden chest pain. Amid ...

The madness began on a Thursday morning. Ewing, fresh off winning an interim bantamweight belt on the regional circuit just a ...